All GLP-1 medications from licensed 503A compounding pharmacies Browse Products

Originally posted by @dontcallmeearl on TikTok · 82s|Watch on TikTok
Full video transcriptClick to expand

Auto-generated transcript of @dontcallmeearl's video. Quoted here for educational fact-check commentary; original creator retains all rights to the video content.

  1. 0:00Alright, so that's our 30 units of the NAD.
  2. 0:05So now I'm just gonna swab my shoulder because that's where I eject it.
  3. 0:11Okay, quite a prayer to baby Jesus because it's so thick it takes a lot to get it in.
  4. 0:30Alright, and that's it.
  5. 0:35Now we just wait for the panic attack to set it.
  6. 0:38So we're a few minutes in from the injection and you can like the heart starts to race a
  7. 0:43little bit.
  8. 0:44You feel kind of warm and flush.
  9. 0:46Your breath is kind of taking away a little bit.
  10. 0:50Like a little bit of lightheadedness.
  11. 0:54It's fun.
  12. 0:56It's a fun sensation.
  13. 0:57But it'll pass.
  14. 0:59Leave it a pass or I'll die.
  15. 1:01No, it'll pass.
  16. 1:02It'll pass and we'll be fine and our cells will regenerate and we'll have a great mood and
  17. 1:06lots of energy.
  18. 1:07It's a small price to pay.
  19. 1:10It's a big price to pay but we're gonna be fine.
  20. 1:13So highly recommend NAD even with a little post-injection roller coaster.

@dontcallmeearl's peptide therapy claims need context

Jeremy earl

TikTok creator

109.9K viewsWatch on TikTok

Quick answer

The creator self-administered an intramuscular NAD+ injection and documented acute symptoms including tachycardia, flushing, dyspnea, and lightheadedness, then normalized these as expected side effects worth tolerating for purported benefits. These vasodilatory and autonomic responses are consistent with documented NAD+ administration reactions, but they require clinical context to distinguish expected transient effects from potentially dangerous cardiovascular responses. NAD+ therapy, while an active area of research in aging and metabolism, lacks sufficient controlled human trial data to support the broad regenerative and mood claims made in the video.

Video review standard

Clinical fact-check snapshot

FormBlends treats social health videos as a starting point, then checks the claim against medical context, source quality, safety limits, and whether licensed provider review belongs in the next step.

Peptide social video fact-checksMedical claim reviewProvider discussion

Evidence signal

Source-backed review

Regulatory reality

Access rules depend on the compound and patient situation

Safety screen

Viral claims can miss contraindications, dose escalation, medication interactions, and quality-control risks.

This page currently connects to 6 source-backed evidence items through visible references or structured citation data.

PubMed evidence trail

Research sources used to frame this page

For @dontcallmeearl's peptide therapy claims need context, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.

Provider decision path

Use local research to choose a safer review path

Direct answer

@dontcallmeearl's peptide therapy claims need context is best used to compare access, oversight, pricing, pharmacy quality, and patient support before starting care.

Evidence check

Directory pages should connect local intent with provider standards, pharmacy transparency, and practical next steps.

Safety check

Provider quality, pharmacy source, prescribing model, and follow-up support can matter as much as the medication name.

Next step

When you are ready, the get-started flow can collect the details needed for a prescription review instead of leaving you to guess.

Page-specific review note

What this exact clip is really saying

This FormBlends review is specific to "@dontcallmeearl's peptide therapy claims need context" from Jeremy earl. We read the clip as a Peptide social video fact-checks claim about Peptide social video fact-checks, then separate the useful signal from what a short social video cannot prove. The page-specific claim focus is: The creator self-administered an intramuscular NAD+ injection and documented acute symptoms including tachycardia, flushing, dyspnea, and lightheadedness, then normalized these as expected side effects worth tolerating for purported benefits.

The reason this review is not generic is the source wording and the canonical claim label "peptides tiktok 7557732432632450318." In this clip, the useful excerpt is: "Alright, so that's our 30 units of the NAD." That wording changes the review because it points to Peptide social video fact-checks evidence, safety, and patient-fit context, not a one-size-fits-all protocol.

The source trail for this page is checked against NAD+ metabolism and its roles in cellular processes during ageing (2021), Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women (2021), and Chronic nicotinamide riboside supplementation is well-tolerated and elevates NAD+ in healthy middle-aged and older adults (2018), plus the creator's own wording. Peptide social video fact-checks decisions still need an eligibility review, medication-interaction screen, access check, and quality-control review before anyone treats a social clip as medical advice.

Rajman et al.
People who land here are usually trying to understand whether the Peptide social video fact-checks claim is evidence-backed, safe, and relevant to their own situation.
The strongest next step is to compare the claim with FormBlends' Peptide social video fact-checks guide, evidence notes, and provider review path before acting.

Claim verdict

The useful answer behind this video

This page is built to answer the specific claim behind the clip, then separate what is useful from what still needs clinical context. That makes the URL more than a repost: it gives Google, readers, and AI retrieval systems a concise verdict with source and safety boundaries.

Claim being checked

The creator self-administered an intramuscular NAD+ injection and documented acute symptoms including tachycardia, flushing, dyspnea, and lightheadedness, then normalized these as expected side effects worth tolerating for purported benefits.

FormBlends verdict

Peptide social video fact-checks evidence, safety, and patient-fit context

Evidence strength

Source-backed review with clinical or regulatory citations.

Patient-safe next step

Compare the claim with FormBlends safety guidance and a licensed-provider review before acting.

What to do with this video

Use the clip as a claim to verify, not a treatment plan

What it helps with

  • The creator self-administered an intramuscular NAD+ injection and documented acute symptoms including tachycardia, flushing, dyspnea, and lightheadedness, then normalized these as expected side effects worth tolerating for purported benefits. These vasodilatory and autonomic responses are consistent with documented NAD+ administration reactions, but they require clinical context to distinguish expected transient effects from potentially dangerous cardiovascular responses. NAD+ therapy, while an active area of research in aging and metabolism, lacks sufficient controlled human trial data to support the broad regenerative and mood claims made in the video.
  • Tachycardia, flushing, dyspnea, and lightheadedness after NAD+ injection are documented reactions, but they overlap symptomatically with anaphylaxis and cardiac events and should not be self-managed without clinical guidance.
  • Rajman et al. (2018, Cell Metabolism) found NAD+ precursors raise tissue NAD+ in animals and early human studies, but controlled trials on intramuscular injection specifically and its clinical outcomes remain limited.

What it may miss

  • It may not cover eligibility, contraindications, medication interactions, lab history, or dose escalation.
  • Compound access, legal status, and product quality still need a separate safety check.
  • Social video captions rarely show the full evidence base behind a claim.

Best next step

Compare the claim against a FormBlends guide, safety page, and licensed-provider review before acting.

Start provider review

What You'll Learn

  • Tachycardia, flushing, dyspnea, and lightheadedness after NAD+ injection are documented reactions, but they overlap symptomatically with anaphylaxis and cardiac events and should not be self-managed without clinical guidance.
  • Rajman et al. (2018, Cell Metabolism) found NAD+ precursors raise tissue NAD+ in animals and early human studies, but controlled trials on intramuscular injection specifically and its clinical outcomes remain limited.
  • The '30 units' dose described is meaningless without knowing the mg/mL concentration of the solution; unit markings on a syringe are not a dose until concentration is specified.
  • Lautrup et al. (2019, Cell Metabolism) reviewed NAD+ and DNA repair pathways but noted that clinical translation to human tissue regeneration is still early-stage, not established benefit.
  • Intramuscular NAD+ is not FDA-approved as a therapeutic and is typically sourced through compounding pharmacies; compounded preparations are not equivalent to any approved drug formulation.
  • Self-injection outside a supervised clinical setting removes access to emergency response if a reaction escalates beyond the expected transient symptoms.
  • NAD+ research in aging and metabolism is a legitimate and active scientific area, but that scientific interest does not validate self-administration protocols based on social media content.

Our take · Written by FormBlends editorial team · Reviewed by FormBlends Medical Team · This is not a transcript. It is our independent review of the video above.

What did @dontcallmeearl actually say?

The creator filmed themselves injecting what they described as 30 units of NAD+ into their shoulder, then documented the aftermath in real time. They described racing heart, flushing, shortness of breath, and lightheadedness, calling it a "fun sensation" and joking, "leave it a pass or I'll die." They finished by saying they "highly recommend NAD even with a little post-injection roller coaster."

To be clear about what was actually claimed: that these side effects are expected, temporary, and worth it for benefits like cell regeneration, better mood, and more energy. The video functions as an informal endorsement of self-administered intramuscular NAD+ injections, side effects included.

Does the science back this up?

The side effects described are real and well-documented. The recommendation to push through them without medical supervision is where things get shakier.

NAD+ (nicotinamide adenine dinucleotide) is a coenzyme involved in cellular energy metabolism and DNA repair. It has genuine research interest, particularly around aging and metabolic function. Rajman et al. (2018, Cell Metabolism) reviewed preclinical and early human data showing NAD+ precursor supplementation can raise tissue NAD+ levels and influence metabolic pathways in aged animals. Human trial data is more limited.

The flushing, tachycardia, and dyspnea described in the video are consistent with what clinicians call "NAD+ infusion reactions." These are more commonly documented with intravenous NAD+, where rate of infusion directly correlates with symptom severity. Braidy et al. (2019, Antioxidants and Redox Signaling) noted that systemic NAD+ administration causes these vasodilatory and autonomic responses. With intramuscular injection, the bolus enters circulation more slowly, but the symptoms can still occur.

What science does not support: the claim that these symptoms are simply a "small price to pay." Tachycardia and shortness of breath following injection warrant clinical assessment, not just waiting it out while filming.

What did they get wrong (or right)?

Credit where it is due: the creator did not claim NAD+ cures anything specific, and they accurately described what the acute reaction actually feels like. The symptoms they listed match clinical reports. That transparency matters.

What they got wrong is the framing. Describing symptomatic tachycardia and dyspnea as "fun" and "a small price to pay" minimizes what are legitimate physiological warning signals. Someone watching this who has an undiagnosed arrhythmia, hypertension, or autonomic dysfunction could have a genuinely dangerous reaction and assume it is normal because this video told them so.

The claim that "cells will regenerate" is also doing a lot of work without evidence. NAD+ precursors have shown some effects on cellular repair pathways in animal models, but the leap to meaningful human tissue regeneration from an intramuscular injection is not established in controlled trials. Lautrup et al. (2019, Cell Metabolism) reviewed the mechanistic basis but noted clinical translation remains early-stage.

Self-injection outside a clinical setting also removes access to monitoring equipment, trained staff, and emergency response if the reaction escalates.

What should you actually know?

If you are considering NAD+ therapy, the side effect profile the creator described is real, and it does typically resolve. That part is accurate. But several things this video glosses over matter significantly.

  • The "30 units" dose mentioned has no context. Syringe unit markings depend entirely on the concentration of the solution. Without knowing the mg/mL concentration, "30 units" means nothing clinically.
  • Intramuscular NAD+ is not FDA-approved as a therapeutic. It is used off-label, often through compounding pharmacies, and the evidence base for specific outcomes is still thin in humans.
  • The symptoms described, racing heart, flushing, shortness of breath, lightheadedness, overlap with anaphylaxis precursors and cardiac events. A clinician should be the one deciding whether your reaction is expected or a signal to stop.
  • NAD+ research is genuinely interesting. That does not mean self-administration based on a TikTok is a reasonable protocol.

If you want to explore NAD+ therapy, do it through a supervised telehealth or in-person clinical provider who can review your cardiac history, monitor your response, and adjust accordingly.

Interested in GLP-1 or peptide therapy?

Get matched with licensed-provider review to help decide if it is right for you.

Free Assessment

About the Creator

Jeremy earl · TikTok creator

109.9K views on this video

@dontcallmeearl's peptide therapy claims need context

Frequently asked questions

Quick answers based on this video and our medical team review.

What does the video say about tachycardia, flushing, dyspnea,?

Tachycardia, flushing, dyspnea, and lightheadedness after NAD+ injection are documented reactions, but they overlap symptomatically with anaphylaxis and cardiac events and should not be self-managed without clinical guidance.

What does the video say about rajman et al. (2018, cell metabolism) found nad+ precursors raise?

Rajman et al. (2018, Cell Metabolism) found NAD+ precursors raise tissue NAD+ in animals and early human studies, but controlled trials on intramuscular injection specifically and its clinical outcomes remain limited.

What does the video say about the '30 units' dose described?

The '30 units' dose described is meaningless without knowing the mg/mL concentration of the solution; unit markings on a syringe are not a dose until concentration is specified.

What does the video say about lautrup et al. (2019, cell metabolism) reviewed nad+?

Lautrup et al. (2019, Cell Metabolism) reviewed NAD+ and DNA repair pathways but noted that clinical translation to human tissue regeneration is still early-stage, not established benefit.

What does the video say about intramuscular nad+?

Intramuscular NAD+ is not FDA-approved as a therapeutic and is typically sourced through compounding pharmacies; compounded preparations are not equivalent to any approved drug formulation.

What does the video say about self-injection outside a supervised clinical setting removes access to emergency?

Self-injection outside a supervised clinical setting removes access to emergency response if a reaction escalates beyond the expected transient symptoms.

Sources & references

Citations extracted from our medical team's review. Click any citation to search PubMed.

Educational use only. This fact-check is editorial content for general information. Nothing here is medical advice. Talk to a licensed provider about your specific situation before starting, stopping, or changing any supplement, peptide, or medication regimen.

Read More on This Topic

Our written guides go deeper with dosing details, comparison tables, and medical-team reviewed protocols.

Not medical advice. This video was made by Jeremy earl, not by FormBlends. Our write-up above is an editorial review, not a medical recommendation. Talk to your doctor before making any decisions about medications or treatments.